Pediatric ADVAIR DISKUS Versus Oral Montelukast Chewable Tablets
Status:
Completed
Trial end date:
2007-04-01
Target enrollment:
Participant gender:
Summary
This study is being conducted to demonstrate the superior clinical effectiveness of
Salmeterol/Fluticasone Propionate compared to montelukast in the management of persistent
asthma in children aged 6-14 years, and to assess the effect of each treatment
[Salmeterol/Fluticasone Propionate (50/100 mcg) and montelukast (5 mg)] on lung function,
asthma control, Health Outcomes including the child's quality of life as measured by
Paediatric Asthma Quality of Life Questionnaire (PAQLQ) and the caregiver's quality of life
as measured by Paediatric Asthma Caregiver's Quality of Life Questionnaire (PACQLQ) at
selected centers where a valid translation is available.